Vanda Pharmaceuticals Inc. (VNDA) › Capital ExpendituresVanda Pharmaceuticals Inc. (VNDA) — Capital ExpendituresAnnual figures by period end, from SEC filings.2011-12-31: $275.0K2012-12-31: $2.02M2013-12-31: $176.0K2014-12-31: $769.0K2015-12-31: $2.53M2016-12-31: $1.41M2017-12-31: $1.66M2018-12-31: $368.0K2019-12-31: $1.02M2020-12-31: $1.79M2021-12-31: $552.0K2022-12-31: $679.0K2023-12-31: $383.0K2024-12-31: $490.0K2025-12-31: $998.0K$998.0K2011-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$998.0K+103.7%2026-02-12From 2025-01-012024-12-31$490.0K+27.9%2026-02-12From 2024-01-012023-12-31$383.0K-43.6%2026-02-12From 2023-01-012022-12-31$679.0K+23.0%2025-02-14From 2022-01-012021-12-31$552.0K-69.2%2024-02-08From 2021-01-012020-12-31$1.79M+76.2%2023-02-09From 2020-01-012019-12-31$1.02M+176.9%2022-02-24From 2019-01-012018-12-31$368.0K-77.9%2021-02-11From 2018-01-012017-12-31$1.66M+18.3%2020-02-26From 2017-01-012016-12-31$1.41M-44.3%2019-02-19From 2016-01-012015-12-31$2.53M+228.6%2018-02-15From 2015-01-012014-12-31$769.0K+336.9%2017-02-17From 2014-01-012013-12-31$176.0K-91.3%2016-02-12From 2013-01-012012-12-31$2.02M+633.5%2015-03-13From 2012-01-012011-12-31$275.0K—2014-02-25From 2011-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)